Embolic Protection Devices Market Snapshot
“From 2023 to 2030, the Embolic Protection Devices market is expected to grow at an 8.45% CAGR. It is expected to increase from USD 0.75 billion in 2023 to more than USD 1.67 billion by 2030.”
By preventing or limiting the quantity of plaque material that reaches the distal bed, embolic protection devices (EPDs) may minimize unfavourable clinical consequences. They are widely used in saphenous vein graft (SVG) treatments as well as carotid artery stenting procedures.
Other arterial beds, such as the renal arteries, are also being researched, but it is not yet known whether they can reduce clinically significant outcomes there. Proximal occlusion aspiration devices, distal occlusion aspiration devices, and distal filters are the three kinds of EPDs that can be divided based on how they function.
A rise in financing and spending for research and development on embolism-protective devices is a major element that is projected to support the market's positive growth. The sector would thrive if technical improvements to remove emboli or blood clots increased.
Along with these factors, the market is anticipated to grow during the forecast period due to the sharp increase in the number of people suffering from various cardiovascular and neurovascular diseases. The market expansion, however, may be hampered by the rise in product failures and recalls.
It is anticipated that the market will expand at a faster rate thanks to the rising number of people suffering from cardiovascular and neurovascular illnesses.
According to the World Health Organization, over 31% of all fatalities worldwide were thought to have been caused by cardiovascular disorders in 2016. In the near future, the market would benefit greatly from increased awareness of the need for pre-diagnostics and better treatment.
A significant issue limiting market expansion is the accessibility of substitutes. The availability of alternatives, particularly at cheaper prices, may make it more difficult to deploy embolic protection technology.
The market value of medical equipment has been hampered in underdeveloped countries by their accessibility. Therefore, having access to indirect substitutes could have a negative effect on the industry share. However, the market will be given the ability to overcome this problem thanks to an increase in government sector investment.
The market for embolic protection devices presents a number of opportunities due to of the rise in cardiovascular disorders, the demand for less invasive operations, and technological developments in the healthcare sector.
Additionally, it is anticipated that the ageing population and rising public awareness of the advantages of embolic protection devices will fuel market expansion. However, factors like the high cost of devices and the restrictive reimbursement policies may partially impede market growth.
The market for embolic protection devices is anticipated to expand significantly during the next few years. Unprecedented obstacles to industrial expansion were posed by the COVID-19 pandemic outbreak. As the number of COVID-19 cases increased, the number of PCI procedures drastically decreased.
Delays in production and disturbances to the supply chain of embolic protection devices were also brought on by the lockdowns' growing logistical problems, which led to temporary product shortages around the world. The sector is, however, gradually regaining its pre-COVID momentum thanks to widespread immunization campaigns and the restart of manufacturing.
>>>Download Sample Report Now:https://marketreportservice.com/request-sample/embolic-protection-devices-market-54591
Growth Drivers
- The trend towards minimally invasive procedures is on the rise.
- The prevalence of cardiovascular diseases is on the rise in developed countries.
- The reimbursement scenario in North America is favorable.
- The advancements in embolic protection devices have significantly improved their efficiency and effectiveness.
- The geriatric population is increasing in developing countries.
Restraints
The market for embolic protection devices is expected to grow due to favorable reimbursement scenarios in American countries and the introduction of advanced devices. However, the availability of cheaper alternatives may slow growth and negatively impact product adoption, as healthcare professionals in developing countries prefer low-cost medical equipment.
Trends
The cardiovascular disease segment is expected to grow significantly due to an increase in cardiovascular diseases and the adoption of embolic protection systems in cardiovascular therapies. Congenital heart disease is diagnosed in 1 in 110 births worldwide, with more diagnoses later in life. The UK performed 19,333 adult heart operations between 2020 and 2021, increasing demand for embolic protection systems, boosting segment growth. This growth is expected to continue over the forecast period.
Over the next seven years, technological advancements in embolic protection devices, such as distal occlusion devices, distal filter devices, and proximal occlusion/flow-reversal devices, are expected to boost the business outlook. These devices, like Medtronic's Mo. Ma Ultra proximal cerebral protection device, use double-occlusion balloon systems to prevent embolic debris during endovascular procedures. Continued research and development will increase their acceptance.
Embolic Protection Devices Market Segment Analysis
The embolic protection devices market is segmented based on type, material, application and end user.
The proximal occlusion systems, distal occlusion systems, and distal filters make up the Type segmentation of the embolic protection devices market. The distal occlusion systems market had a market size of more than USD 300 million in 2022 and is anticipated to grow significantly over the forecast period. This is due to the benefits of distal filters, including their use, availability in a variety of specifications, and lack of interference with the capacity to see lesions.
Nitinol and polyurethane are the two material subgroups used to segment the embolic protection device market. By 2030, it is expected that the polyurethane segment will reach USD 950 million. The development of embolic medical devices for several minimally invasive biomedical applications has made substantial use of polyurethane, which will help the segment grow. Additionally, its capacity to be stored in a secondary shape and recover its original shape upon exposure to environmental stimuli like heat and water will increase demand.
The neurovascular disease, cardiovascular disease, and peripheral disease segments of the embolic protection devices market are separated based on application. In 2022, the cardiovascular disease segment generated more than USD 500 million in revenue. Global heart disease incidence is on the rise, which will boost industry statistics. Additionally, the widespread use of embolic protection devices for the prevention of stroke and the emerging product demand in percutaneous coronary intervention (PCI), transcatheter aortic valve replacement (TAVR), and other cardiac interventions will favour the outlook for the segment.
The embolic protection devices market is divided according to end-use into ambulatory surgery centers, hospitals, and other places. By 2030, the market for ambulatory surgical centers is expected to reach USD 880 million. Ambulatory surgery centers offer many advantages that will drive company expansion, including low costs for high-quality care, quick recovery times, and less chance of hospital-acquired infections.
Embolic Protection Devices Market Key Vendors
The embolic protection devices market Key Vendors includes Boston Scientific, Medtronic, Abbott, Cordis (A Cardinal Health Company), Allium Medical Solutions, Contego Medical, W.L. Gore & Associates, Silk Road Medical, Claret Medical, AngioSlide.
New Developments
17 September 2022: Boston Scientific Corporation had announced results from the PROTECTED TAVR clinical trial evaluating the SENTINEL™ Cerebral Protection System, which is designed to capture and remove embolic debris stemming from transcatheter aortic valve replacement (TAVR) before it can reach the brain and potentially cause a stroke.
In November 2022, Innovative Cardiovascular Solutions sponsored a clinical study to evaluate the safety, effectiveness, and performance of the EMBLOK embolic protection systems (EPS) during transcatheter aortic valve replacement (TAVR) by randomized comparison with a commercially available embolic protection device.
In June 2022, Filterlex Medical publicized results from a first-in-human (FIH) study demonstrating the safety, feasibility, and performance of the Captis device, a full-body embolic protection device that reduces the risk of stroke and other complications during left-heart procedures.
05 October 2021: Boston Scientific announced positive results for the Ranger™ Drug-Coated Balloon (DCB) during a late-breaking clinical trial presentation at the Vascular InterVentional Advances (VIVA) meeting in Las Vegas.
Embolic Protection Devices Market Regional Analysis
In 2022, North America held a 35.5% market share for embolic protection devices, and the region is expected to have rapid expansion in the years to come. The region's growing desire for transcatheter aortic valve replacement procedures (TAVR) and the rising patient population suffering from chronic diseases will shape the market landscape. Additionally, the statistics for the North American market will benefit from the rise in obesity cases brought on by changes in lifestyle, unhealthy eating patterns, and the region's stronghold of major industry players. The industry for embolic protection devices will grow faster as a result of end customers being encouraged to use new goods and technologically improved processes.
The North American population's high prevalence of cardiac complications is expected to increase demand for embolic protection systems. Around 2.4 million Canadians have heart disease, making embolic protection systems essential. Research funding for heart and related diseases is also expected to drive market growth in North America. The estimated funding for Coronary Heart Disease research in 2023 is USD 397 million, boosting market growth. Overall, the increasing prevalence of heart and related diseases in the North American population is driving demand for embolic protection systems.
The Asia Pacific market is experiencing rapid growth due to factors such as an aging population, increased cardiovascular disease prevalence, healthcare infrastructure investments, and improved access to services. Demand for embolic protection devices is also driven by rising disposable income, expanding medical tourism, and growing awareness of minimally invasive procedures. Government initiatives and collaborations among regional and international market players are expected to drive growth in the coming years.
Segments Covered in Embolic Protection Devices Market
Embolic Protection Devices Market by Type
- Distal Filter
- Distal Occlusion
- Proximal Occlusion
Embolic Protection Devices Market by Material
Embolic Protection Devices Market by Application
- Cardiovascular
- Neurovascular
- Peripheral
Embolic Protection Devices Market by Application
- Hospitals
- Ambulatory Surgical Centers
- Others
Frequently Asked Questions
What is the worth of embolic protection devices market?
From 2023 to 2030, the Embolic Protection Devices market is expected to grow at an 8.45% CAGR. It is expected to increase from USD 0.75 billion in 2023 to more than USD 1.67 billion by 2030.
What is the size of the North America embolic protection devices industry?
North America held more than 36 % of the embolic protection devices market revenue share in 2022 and will witness expansion in the forecast period.
What are some of the market's driving forces?
It is anticipated that the market will expand at a faster rate thanks to the rising number of people suffering from cardiovascular and neurovascular illnesses.
Which are the top companies to hold the market share in embolic protection devices market?
The embolic protection devices market key players includes Boston Scientific, Medtronic, Abbott, Cordis (A Cardinal Health Company), Allium Medical Solutions, Contego Medical, W.L. Gore & Associates, Silk Road Medical, Claret Medical, AngioSlide.
What is the leading application of embolic protection devices market?
The neurovascular disease, cardiovascular disease, and peripheral disease segments of the embolic protection devices market are separated based on application. In 2022, the cardiovascular disease segment generated more than USD 500 million in revenue.
Which is the largest regional market for embolic protection devices market?
In 2022, North America held a 35.5% market share for embolic protection devices, and the region is expected to have rapid expansion in the years to come. The region's growing desire for transcatheter aortic valve replacement procedures (TAVR) and the rising patient population suffering from chronic diseases will shape the market landscape.
1. SUMMARY
1.1. Embolic Protection Devices Market Overview
1.2. Key Insights
1.3. Report Scope
1.4. Research Methodology
1.5. Frequently Asked Questions
1.6. Chapter Outlines
- DECISION-MAKING SUMMARY
- INTRODUCTION
3.1. Overview of Embolic Protection Devices
3.2. Key Historical Events
3.3. Structure
3.4. Biochemical Interaction
3.5. Target Indications
3.6. Advantages of Embolic Protection Devices
3.7 Challenges associated with Embolic Protection Devices
3.8. Future Perspectives.
- MARKET LANDSCAPE
4.1. Methodology
4.2 Embolic Protection Devices: Developer Landscape
4.2.1. Analysis by Year of Establishment
4.2.2. Analysis by Company Size
4.2.3. Analysis by Location of Headquarters (Region-wise)
4.2.4. Analysis by Location of Headquarters (Country-wise)
4.2.5. Analysis by Year of Establishment, Company Size and Location of Headquarters (Region-wise)
4.2.6. Most Active Players
- COMPANY
5.1. Company Overview
5.1.2 Management Team
5.1.3. Product Portfolio
5.1.4. Recent Developments and Future Outlook
- PARTNERSHIPS AND COLLABORATIONS
6.1. Partnership Models
6.2. Embolic Protection Devices: Partnerships and Collaborations
6.2.1. Analysis by Year of Partnership
6.2.2. Analysis by Type of Partnership
6.2.3. Analysis by Year and Type of Partnership
6.2.4. Analysis by Type of Partner
6.2.5. Analysis by Year of Partnership and Type of Partner
6.2.6. Analysis by Type of Partnership and Type of Partner
6.2.7. Analysis by Type of Partner and Parent Company Size
- ACADEMIC GRANTS ANALYSIS
7.1. Methodology and Key Parameters
7.2. Embolic Protection Devices: Academic Grants Analysis
7.2.1. Analysis by Year of Grant Award
7.2.2. Analysis by Amount Awarded
7.2.3. Analysis by Funding Institute Center
7.2.4. Analysis by Support Period
7.2.5. Analysis by Funding Institute Center and Support Period
7.2.6. Analysis by Type of Grant Application
7.2.7. Analysis by Purpose of Grant
- PUBLICATION ANALYSIS
8.1. Analysis Methodology and Key Parameters
8.2. Embolic Protection Devices: Publication Analysis
8.2.1. Analysis by Year of Publication
8.2.2. Analysis by Type of Publication
8.2.3. Analysis by Type of Conjugate
8.2.4. Analysis by Target Indication
8.2.5. Analysis by Copyright Holder
8.2.6. Word Cloud: Emerging Focus Area
8.2.7. Most Active Publishers: Analysis by Number of Publications
- SUCCESS PROTOCOL ANALYSIS
9.1. Methodology and Key Parameters
9.2. Key Assumptions and Scoring Criteria
9.3. Success Protocol Analysis
9.4. Assessment of Approved Embolic Protection Devices
- Appendix 1: Tabulated Data
- Appendix 2: List of Companies
- Boston Scientific
- Medtronic
- Abbott
- Cordis (A Cardinal Health Company)
- Allium Medical Solutions
- Contego Medical
- L. Gore & Associates
- Silk Road Medical
- Claret Medical
- AngioSlide
